Clinical Trials Directory

Trials / Completed

CompletedNCT01241695

Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Fresenius Kabi · Industry
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine the safety, acceptability and the efficacy of a 12-week intervention with a diabetes-specific oral nutritional supplement on glycaemic control in type 2 diabetic patients with or at risk of malnutrition

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOral nutritional supplement, food for special medical purposes2 servings of 200 ml per day, treatment period: 12 weeks
DIETARY_SUPPLEMENTOral nutritional supplement, food for special medical purposes2 servings of 200 ml per day, treatment period: 12 weeks

Timeline

Start date
2010-11-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2010-11-16
Last updated
2012-07-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01241695. Inclusion in this directory is not an endorsement.

Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsa (NCT01241695) · Clinical Trials Directory